- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Preoperative CT sways heart surgery's outcome
Findings from a Washington, DC, study suggest that cardiac CT performed before a repeat surgical revascularization may lead to safer and more cost-effective operations.
Findings from a Washington, DC, study suggest that cardiac CT performed before a repeat surgical revascularization may lead to safer and more cost-effective operations. Pre-op CT was also linked to a higher likelihood of improved peri- and postoperative outcomes in these patients.
Dr. Gabriel Maluenda and colleagues at the Washington Hospital Center reviewed a series of 364 consecutive patients who underwent a repeat sternotomy for bypass grafting repair or other revascularization procedures. Of these, 136 had been referred for cardiac CT to provide guidance to surgeons. The investigators found that patients who underwent scanning had a statistically significant chance of suffering less bleeding and fewer heart attacks and of enjoying shorter spells in intensive care. Maluenda presented study results at the 2009 Society of Cardiovascular Computed Tomography meeting.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
